The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: Edison issues review on Seneca Global Income & Growth Trust (SIGT)

23 Mar 2017 12:28

Edison Investment Research Limited / Key word(s): Research Update Edison Investment Research Limited: Edison issues review on Seneca Global Income & Growth Trust (SIGT) 23-March-2017 / 13:28 GMT/BST


London, UK, 23 March 2017

Edison issues review on Seneca Global Income & Growth Trust (SIGT)

Seneca Global Income & Growth Trust (SIGT) aims to generate income and long-term capital growth across multiple asset classes with low volatility. The trust adopts a long-term strategic asset allocation to equities (60%, split 35% to UK and 25% to overseas - with modest US exposure), fixed income (15%) and specialist assets (25%, generally yielding 5-8%). Shorter-term tactical asset allocations are made with a view to enhancing portfolio returns. For UK equity exposure, SIGT focuses on mid-cap companies, which over time tend to outperform the broader market. SIGT retains zero exposure to developed market government bonds, which the manager considers expensive. Following the change in mandate in 2012, SIGT's NAV total return has outperformed the FTSE All-Share index, with significantly lower volatility; while dividends and reserves have grown every year.

SIGT's shares are currently trading at a 0.7% premium to cum-income NAV, this compares to the 0.4% average discount of the last 12 months (range of a 3.3% premium to a 5.6% discount), and the discounts of the last three, five and 10 years (range of 2.5% to 6.9%). Since the change in mandate in 2012, SIGT has regularly increased its annual dividend; its prospective yield is 3.6%, which compares favourably to its peers in the AIC Flexible Investment sector.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv

Dissemination of a UK FINANCIAL NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

557581 23-March-2017 

corporate-announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

Date   Source Headline
7th Feb 202011:49 amRNSNet Asset Value(s)
6th Feb 202012:03 pmRNSNet Asset Value(s)
5th Feb 202011:40 amRNSNet Asset Value(s)
4th Feb 202011:23 amRNSNet Asset Value(s)
3rd Feb 202012:44 pmRNSNet Asset Value(s)
3rd Feb 202010:36 amRNSTotal Voting Rights
31st Jan 202011:25 amRNSNet Asset Value(s)
30th Jan 202011:20 amRNSNet Asset Value(s)
29th Jan 202010:50 amRNSNet Asset Value(s)
28th Jan 202011:00 amRNSNet Asset Value(s)
27th Jan 202012:00 pmRNSNet Asset Value(s)
24th Jan 202011:33 amRNSNet Asset Value(s)
23rd Jan 202011:50 amRNSNet Asset Value(s)
22nd Jan 202011:18 amRNSNet Asset Value(s)
21st Jan 20202:35 pmRNSNet Asset Value(s)
20th Jan 202012:25 pmRNSNet Asset Value(s)
17th Jan 202012:11 pmRNSNet Asset Value(s)
16th Jan 202010:56 amRNSNet Asset Value(s)
15th Jan 202011:36 amRNSNet Asset Value(s)
14th Jan 202010:49 amRNSNet Asset Value(s)
13th Jan 20204:17 pmRNSIssue of Equity
13th Jan 202011:06 amRNSNet Asset Value(s)
10th Jan 20204:41 pmRNSIssue of Equity
10th Jan 202010:49 amRNSNet Asset Value(s)
9th Jan 20204:28 pmRNSIssue of Equity
9th Jan 202010:44 amRNSNet Asset Value(s)
8th Jan 202011:16 amRNSNet Asset Value(s)
7th Jan 202011:18 amRNSNet Asset Value(s)
6th Jan 20204:20 pmRNSIssue of Equity
6th Jan 20201:40 pmRNSNet Asset Value(s)
3rd Jan 20204:28 pmRNSIssue of Equity
3rd Jan 202011:21 amRNSNet Asset Value(s)
2nd Jan 202010:57 amRNSNet Asset Value(s)
2nd Jan 20209:38 amRNSTotal Voting Rights
31st Dec 201910:09 amRNSNet Asset Value(s)
30th Dec 201910:34 amRNSNet Asset Value(s)
27th Dec 201910:46 amRNSNet Asset Value(s)
24th Dec 201910:52 amRNSNet Asset Value(s)
23rd Dec 201912:01 pmRNSNet Asset Value(s)
23rd Dec 20198:37 amRNSBlock listing Interim Review
20th Dec 201911:18 amRNSNet Asset Value(s)
19th Dec 201910:42 amRNSNet Asset Value(s)
18th Dec 201911:25 amRNSNet Asset Value(s)
17th Dec 201910:47 amRNSNet Asset Value(s)
16th Dec 20194:26 pmRNSTransaction in Own Shares
16th Dec 201912:22 pmRNSNet Asset Value(s)
13th Dec 201911:09 amRNSNet Asset Value(s)
12th Dec 201910:51 amRNSNet Asset Value(s)
11th Dec 201910:33 amRNSNet Asset Value(s)
10th Dec 201911:21 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.